UAE Cold Pain Therapy Market Report 2022 to 2030

UAE Cold Pain Therapy Market Analysis

$ 3999

The UAE Cold Pain Therapy Market was valued at $11 Mn in 2022 and is predicted to grow at a CAGR of 6.2% from 2023 to 2030, to $18 Mn by 2030. The key drivers of this industry include an upward trend in the incidence of pain disorders, technological advances in the industry, and supportive government policies. The industry is primarily dominated by players such as Julphar, Hisamitsu, Rapid Aid, Ossur, Zimmer Biomet, Breg, and Pfizer among others.

ID: IN10AEPH310 CATEGORY: Pharmaceuticals GEOGRAPHY: UAE AUTHOR: Riddhi Solanki

Buy Now

UAE Cold Pain Therapy Market Analysis Executive Summary

The UAE Cold Pain Therapy Market is at around $11 Mn in 2022 and is projected to reach $18 Mn in 2030, exhibiting a CAGR of 6.2% during the forecast period.

Cryotherapy, also known as cold pain therapy, is the use of cold substances to reduce pain. It activates the body's active anti-inflammatory response and causes the production of endorphins, resulting in decreased inflammation, and discomfort. Ice packs are the most popular type of cold pain therapy due to their low cost, convenience, and drug-free properties, making them useful for treating pain caused by sprains, fractures, strains, tendinitis, and superficial tissue injury. This treatment strategy is effective for both acute injuries like sprains, strains, and bruises, as well as chronic problems like arthritis and musculoskeletal disorders. It is available in various forms, including ice packs, cooling towels, compresses, wraps, and pads, as well as prescription-based motorized and non-motorized devices. Key companies offering products for this therapy include Beiersdorf AG, DJO Global, Inc., Hisamitsu Pharmaceutical Co., Inc., Romsons Group of Industries, Polar Products, Rapid Aid, and others.

Back pain is the most prevalent pain disorder in the UAE affecting more than 60% of the population. The market is being fuelled by significant factors such as the growing aging population which results in a rise in the occurrence of pain disorders, technological advances in the industry, and supportive government policies. However, conditions such as accessibility challenges, limited insurance coverage, and high costs of equipment restrict the growth and potential of the market.

Market Dynamics

Market Growth Drivers

Surge in prevalence of pain disorders: Lifestyle disorders such as osteoarthritis, chronic pain, and others are highly prevalent in the UAE necessitating the use of effective pain management approaches. More than 60% of the Emirati population suffers from back pain which is the most common condition. This trend is driven by factors such as an aging demographic and a surge in fitness and sports activities, contributing to market growth.

Technological advancements: The Cold Pain therapeutic market is experiencing constant innovations and advancements in technology such as wearable wraps, localized cooling systems, and others. These advancements have the potential to improve treatment efficacy and ease of use, promoting market growth.

Supportive government policies: The UAE government allocates resources and funds to enhance the medical infrastructure and accessibility of patients to health care providers and quality treatments. It also provides support to research and development activities to encourage novel technologies in cold pain therapeutics, leading to market expansion.

Market Restraints

Accessibility challenges: UAE faces a shortage of healthcare professionals with sufficient expertise and training in utilizing cold-pain therapies which is especially observed in rural areas. This limitation restricts patients in remote locations from accessing and benefiting from these therapies. Similarly, the availability of specialized devices such as cryotherapy chambers is frequently restricted, particularly in areas outside of major hospitals and clinics, limiting patient adoption of treatment modalities.

Limited insurance coverage: Cold pain therapy is not covered under insurance within the UAE health care system, posing a significant financial barrier for patients while opting for therapies utilizing sophisticated technologies like cryotherapy chambers.

High costs of equipment: Individual patients and local medical facilities have limited access to cryotherapy chambers and other complex cold therapy technologies due to their high costs. This can result in the use of economical traditional pain management approaches or easily accessible over-the-counter pain medicines as more cost-effective options.

Healthcare Policies and Regulatory Landscape

The Dubai Health Authority (DHA) is the primary regulatory authority for healthcare and drugs in the UAE. DHA manages and regulates Dubai's healthcare sector, which includes treatment approval and licensing. It establishes and enforces standards, guidelines, and regulations to ensure the safety, efficacy, and quality of pharmaceuticals and medical devices in the emirate.

For new entrants looking to introduce therapeutics into the UAE market requires understanding and following the DHA's regulations. The regulatory framework emphasizes patient safety and quality, resulting in a strong and reliable environment for medical treatments in the country.

The DHA conducts a thorough review including drug safety, quality, and efficiency before issuing licenses in the UAE.

Competitive Landscape

Key Players

Julphar
DJO Global Inc
Hisamitsu Pharmaceutical
DeRoyal Industries
Zimmer Biomet
BREG
Rapid Aid
Chattanooga
Pfizer
Ossur

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

UAE Cold Pain Therapy Market Segmentation

By Therapy Type

Icepack
Chamber
Cryosurgery

By Product Type

OTC Products
Prescription Drugs

By Application

Dermatology
Oncology
Musculoskeletal disorders
Pain management
Sports medicine
Ophthalmology
Others

By End Users

Hospitals and clinics
Sports person
Adults
Others

By Distribution channel

Hospital pharmacies
Retail pharmacies
Online pharmacies

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.